Found 5 matching trials
Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma PHASE1 The purpose of the study is to determine 1) the safety of administration of...
Show More Location
University of Virginia
Learn More & Join Trial
Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma PHASE1 The goals of this study are to evaluate 1) the safety of administration of ...
Show More Location
University of Virginia
Learn More & Join Trial
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients PHASE1 The purpose of this study is to learn the effects an experimental vaccine (...
Show More Location
University of Virginia
Learn More & Join Trial
Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma PHASE2 This is an open-label, phase II study of a vaccine comprising melanoma pept...
Show More Location
University of Virginia
Learn More & Join Trial
Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma PHASE2 This pilot phase II trial studies how well epacadostat and vaccine therapy ...
Show More Location
Emory University/Winship Cancer Institute
Learn More & Join Trial